Genmab A/S Income Statement Analysis

Revenue, earnings, and profit margins in billions USD

Scroll to see more
Genmab A/S income statement - Annual data in billions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Revenue & Gross Profit
Revenue2.992.4414.518.481.665.393.04
Cost of Revenue0.140.030.000.000.000.000.00
Gross Profit2.852.4114.511.291.660.000.00
Operating Expenses
Research & Development1.341.135.564.180.522.241.30
Selling, General & Administrative0.530.492.681.280.110.350.22
Operating Expenses1.871.628.245.460.622.591.52
Operating Income0.980.796.273.021.042.801.52
Other Income/Expense
Interest Income0.140.150.050.200.030.120.06
Interest Expense-0.02-0.010.010.010.000.010.00
Other Income/Expense0.18-0.600.660.78-0.58-0.050.05
Income
Income Before Tax1.270.848.313.980.972.891.64
Income Tax Expense0.180.191.490.980.190.720.16
Net Income1.090.656.813.010.782.171.47
Net Income - Continuous Operations1.090.650.780.450.000.000.00
Net Income - Discontinued Operations0.000.000.000.000.000.000.00
EBITDA1.030.828.654.241.083.011.70
EBIT0.980.798.284.001.042.871.61
Depreciation & Amortization0.040.030.050.030.040.000.00
Earnings Per Share
Basic EPS17.0010.0083.007.0012.003.002.00
Diluted EPS17.0010.0083.007.0012.003.002.00
Basic Shares Outstanding0.060.070.070.070.070.630.61
Diluted Shares Outstanding0.060.070.070.070.070.640.62